REVAX Performance — RBC Emerging Markets Value Equity Fund, Class A
Data updated: 2026-08-26
REVAX returned +24.71% year to date and +50.59% over one year to Jun 2026. Over one year the fund beat its Emerging Markets Equity category average: $100 grew to $151, against $141 for the category. Volatility over the past 12 months was 22.91% a year. In the 12 months to Jun 2026 the fund took in a net $16.0M, and assets reached $119.45M.
REVAX Growth of $100
What $100 invested in RBC Emerging Markets Value Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | REVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $151 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $197 | $179 |
| Since data start (Apr 2022 – Jun 2026) | $194 | $166 |
REVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +24.71% |
| 1 year | +50.59% |
3- and 5-year figures withheld: returns differ from sibling classes.
REVAX Annual Returns
Calendar-year total returns of RBC Emerging Markets Value Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +24.71% |
| 2025 | +46.97% |
| 2024 | +4.21% |
| 2023 | +10.92% |
| 2022 (Apr–Dec) | −8.51% |
REVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.8% | +6.2% | −11.4% | +13.8% | +7.5% | −2.2% | — | — | — | — | — | — |
| 2025 | +1.8% | +2.8% | +1.8% | 0.0% | +6.2% | +7.6% | +0.2% | +3.8% | +6.4% | +5.8% | −0.8% | +4.0% |
| 2024 | −4.1% | +5.0% | +3.5% | +1.0% | +1.1% | +1.6% | −1.4% | +0.8% | +7.4% | −5.1% | −3.1% | −1.9% |
| 2023 | +10.3% | −7.0% | +2.1% | −1.0% | −2.6% | +6.3% | +5.7% | −6.9% | −2.4% | −4.6% | +7.2% | +5.3% |
| 2022 | — | — | — | −4.3% | +1.7% | −6.3% | +0.1% | −1.4% | −10.6% | −1.3% | +17.5% | −2.0% |
REVAX Risk
Risk measures from monthly returns over Jul 2025 – Jun 2026.
- 1-year volatility (annualised): 22.91%
- Best month: +13.76% (Apr 2026)
- Worst month: −11.44% (Mar 2026)
REVAX Fund Flows
Monthly money in and out of RBC Emerging Markets Value Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $16.0M
- 12-month gross sales (incl. reinvestments): $56.9M
- Sales ÷ redemptions: 1.39×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.4M | $1.2M | $1.2M |
| May 2026 | $878K | $2.2M | −$1.3M |
| Apr 2026 | $700K | $2.2M | −$1.5M |
| Mar 2026 | $1.2M | $3.1M | −$1.9M |
| Feb 2026 | $4.3M | $4.0M | $217K |
| Jan 2026 | $6.6M | $2.5M | $4.2M |
| Dec 2025 | $3.8M | $13.1M | −$9.3M |
| Nov 2025 | $19.2M | $8.7M | $10.5M |
| Oct 2025 | $641K | $1.3M | −$691K |
| Sep 2025 | $15.4M | $434K | $15.0M |
| Aug 2025 | $1.0M | $372K | $660K |
| Jul 2025 | $690K | $1.8M | −$1.1M |
REVAX Assets Under Management
Net assets of RBC Emerging Markets Value Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $119.45M |
| 2026-03-31 | $101.28M |
| 2025-12-31 | $94.85M |
| 2025-09-30 | $87.65M |
| 2025-06-30 | $65.30M |
| 2025-03-31 | $57.73M |
| 2024-12-31 | $55.71M |
| 2024-09-30 | $63.12M |
| 2024-06-28 | $62.14M |
| 2024-03-28 | $65.57M |
| 2023-12-29 | $66.36M |
| 2023-09-29 | $65.09M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.